Mesothelioma.com Resources for Patients and their Families

USS Cassin (DD-372)

USS Cassin (DD-372)

The USS Cassin (DD-372) served in the US Navy for over a decade during the first half of the 20th century. She was named for Stephen Cassin, who served with the US Navy during the War of 1812. Cassin was designed as a Mahan-class ship.

Construction

Cassin was laid down in Philadelphia, Pennsylvania at the Philadelphia Navy Yard in October 1934. She was launched in October 1935 and commissioned in August 1936, under the command of Commander A.G. Noble. Cassin carried a crew of 158 and had a cruising speed of 36.5 knots. She was armed with five five-inch guns, four heavy machine guns, and twelve 21-inch torpedo tubes.

Naval History

Cassin made her first voyage to the Caribbean and Brazil in 1937. She then headed to the Pacific to join the forces at Pearl Harbor. She then spent time in Samoa, Australia, and Fiji before returning to Pearl Harbor in late 1941.

On December 7, 1941, Cassin was in drydock (along with USS Downes and USS Pennsylvania). When a bomb hit Downes’ fuel tanks, the fire spread to Cassin. The fire was uncontrollable, and both Downes and Cassin were considered total losses. Cassin was decommissioned immediately.

The remains of Cassin were towed to Mare Island Navy Yard, where she was rebuilt. In February 1944, Cassin was re-commissioned. Later in 1944, the newly rebuilt Cassin participated in an attack on Aguijan Island. She also participated in the bombardment of Marcus Island and helped prepare the air strikes on the Japanese air fields at Manila.

During the Leyte landings, Cassin was positioned northeast of Luzon. After the successful landings, she joined the Battle for Leyte Gulf. During the battle, Cassin screened carriers as they launched aircraft.

In late 1944 and early 1945, Cassin was involved in the assaults on Iwo Jima. She later ran escort duty for supplies and hospital facilities for the island. She remained in the Iwo Jima area for much of the remainder of World War II.

Cassin endured a typhoon in June 1945, during which one man was lost overboard. She returned to the US in November 1945 and was decommissioned later that year. After receiving six battle stars for service during World War II, Cassin was sold and broken up for scrap in 1947.

Asbestos Risk on the USS Cassin (DD-372)

The installation of asbestos in the construction of naval vessels was ordered by law in the US in the early 1930s, after a fire at sea aboard the SS Morro Castle resulted in enormous loss of life. Vessels like Cassin utilized asbestos-containing materials extensively, especially in boilers and engineering rooms, and to insulate pipes all over the vessel. Asbestos has long been known for its ability to insulate; however, it was also proven to be the main cause of life-threatening illnesses like pleural plaques and pleural mesothelioma.

The survival rate of mesothelioma victims is very low - but treatments including radiation for mesothelioma can offer some hope and may increase survival time. Because mesothelioma is an uncommon condition, not all hospitals or health-care providers are able to provide treatment for mesothelioma. To learn more about mesothelioma treatment experts and cancer centers, please request a free copy of our mesothelioma information package. It contains complete information about victim’s legal rights, choices for medical treatment, a list of open clinical trials nationwide and more. All you have to do is complete the form on this page and your package will be on the way.

Sources

Sources

Haze Gray & Underway. Dictionary of American Naval Fighting Ships. DD-372.
http://www.hazegray.org/danfs/destroy/dd372txt.htm Retrieved 8 January 2011.

NavSource Naval History, USS Cassin (DD-372).
http://www.navsource.org/archives/05/372.htm Retrieved 8 January 2011.

Mesothelioma Cancer Alliance Blog

FEATURING:


January 11, 2017
Jillian McKee

New Mesothelioma Clinical Trial Tests Immunotherapy Before Surgery

“Last fall, the Baylor College of Medicine Mesothelioma Treatment Center began running a new clinical trial that looks at how to use immunotherapy and surgery together as a more effective way to treat mesothelioma – an extremely rare form of cancer caused by exposure to asbestos.”